IRIS
Lleo De Nalda, Ana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.079
AS - Asia 5.067
EU - Europa 2.042
SA - Sud America 990
AF - Africa 264
Continente sconosciuto - Info sul continente non disponibili 243
OC - Oceania 11
AN - Antartide 1
Totale 18.697
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.809
SG - Singapore 2.940
CN - Cina 949
BR - Brasile 810
IT - Italia 687
VN - Vietnam 470
FI - Finlandia 286
IE - Irlanda 211
DE - Germania 174
NG - Nigeria 170
HK - Hong Kong 152
CA - Canada 140
GB - Regno Unito 135
FR - Francia 133
IN - India 97
SE - Svezia 94
NL - Olanda 81
AR - Argentina 66
BD - Bangladesh 61
AE - Emirati Arabi Uniti 53
TR - Turchia 50
MX - Messico 46
RU - Federazione Russa 46
IQ - Iraq 43
ID - Indonesia 32
PK - Pakistan 30
BE - Belgio 29
ZA - Sudafrica 28
EC - Ecuador 27
ES - Italia 23
JP - Giappone 23
PH - Filippine 23
CO - Colombia 22
IL - Israele 22
PL - Polonia 22
UA - Ucraina 21
MK - Macedonia 20
CL - Cile 19
CZ - Repubblica Ceca 17
MA - Marocco 15
VE - Venezuela 15
CR - Costa Rica 14
MY - Malesia 13
SA - Arabia Saudita 13
UZ - Uzbekistan 13
NP - Nepal 12
PY - Paraguay 12
ET - Etiopia 11
JO - Giordania 11
KE - Kenya 10
KZ - Kazakistan 10
TT - Trinidad e Tobago 10
AU - Australia 9
DO - Repubblica Dominicana 9
HN - Honduras 9
RO - Romania 9
AT - Austria 8
BB - Barbados 8
DZ - Algeria 8
JM - Giamaica 8
EG - Egitto 7
KR - Corea 7
PE - Perù 7
UY - Uruguay 7
AZ - Azerbaigian 6
GR - Grecia 6
OM - Oman 6
RS - Serbia 6
TN - Tunisia 6
IR - Iran 5
LT - Lituania 5
NI - Nicaragua 5
AL - Albania 4
CH - Svizzera 4
GT - Guatemala 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
BO - Bolivia 3
DK - Danimarca 3
EU - Europa 3
GD - Grenada 3
HR - Croazia 3
KG - Kirghizistan 3
NO - Norvegia 3
PA - Panama 3
PT - Portogallo 3
BS - Bahamas 2
GE - Georgia 2
GP - Guadalupe 2
LB - Libano 2
LK - Sri Lanka 2
ML - Mali 2
MM - Myanmar 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
SN - Senegal 2
SV - El Salvador 2
TW - Taiwan 2
AO - Angola 1
Totale 18.435
Salva come PNG Salva come JPEG
Città #
Singapore 1.370
Chandler 957
Wilmington 835
San Jose 663
Ashburn 610
Dallas 533
The Dalles 413
Shanghai 365
San Mateo 313
New York 285
Helsinki 284
Council Bluffs 278
Milan 271
Ann Arbor 266
Beijing 251
Dublin 208
Boardman 189
Princeton 169
Benin City 167
Lawrence 156
Santa Clara 155
Ho Chi Minh City 152
Los Angeles 148
Hong Kong 144
Leawood 141
Hanoi 126
Paris 96
Rome 96
Phoenix 81
São Paulo 71
Woodbridge 71
Fairfield 70
Amsterdam 58
Buffalo 56
London 53
Seattle 51
Toronto 47
Brooklyn 37
Atlanta 34
Chicago 34
Houston 32
North Bergen 31
Naples 30
Brussels 29
San Diego 29
Charlotte 28
Da Nang 27
Miami 27
Orem 27
Columbus 25
Philadelphia 25
Chennai 24
Falkenstein 24
San Francisco 24
Baghdad 22
Montreal 22
Brasília 20
Denver 20
Las Vegas 20
Boston 18
Frankfurt am Main 18
Haiphong 18
Pune 18
The Bronx 18
Tokyo 18
Munich 17
Redwood City 17
Rio de Janeiro 17
Turin 17
Abbiategrasso 16
Assago 16
Dhaka 16
Stockholm 16
Warsaw 16
Kocaeli 15
Queens 15
Belo Horizonte 14
Figino 14
Johannesburg 14
Mexico City 13
Norwalk 13
Tashkent 13
Campinas 12
Chula Vista 12
Cleveland 12
Guarulhos 12
Guayaquil 12
Porto Alegre 12
Brno 11
Cincinnati 11
Manchester 11
Newark 11
Addis Ababa 10
Amman 10
Bologna 10
Detroit 10
Sacramento 10
San José 10
Biên Hòa 9
Buenos Aires 9
Totale 11.351
Salva come PNG Salva come JPEG
Nome #
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 232
BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection? 220
All That Glitters is Not Gold in Vedolizumab Therapy for Patients With Inflammatory Bowel Diseases and Primary Sclerosing Cholangitis 154
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 152
Alpha-fetoprotein screening in patients with hepatitis C-induced cirrhosis who achieved a sustained virologic response in the direct-acting antiviral agents era 150
A 'Multiomic' Approach of Saliva Metabolomics, Microbiota, and Serum Biomarkers to Assess the Need of Hospitalization in Coronavirus Disease 2019 139
Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosis 133
Innate Immunity and Primary Biliary Cirrhosis 129
Apotopes and the biliary specificity of primary biliary cirrhosis 129
Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosis 129
Mapping the human genetic architecture of COVID-19 129
The limitations and hidden gems of the epidemiology of primary biliary cirrhosis 126
X chromosome gene methylation in peripheral lymphocytes from monozygotic twins discordant for scleroderma 126
Genetic associations in Italian primary sclerosing cholangitis : heterogeneity across Europe defines a critical role for HLA-C 126
Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options 125
B cell depletion therapy exacerbates murine primary biliary cirrhosis 123
The consequences of apoptosis in autoimmunity 122
Clinical Outcomes in the Second versus First Pandemic Wave in Italy: Impact of Hospital Changes and Reorganization 122
Cholangiocarcinoma-on-a-chip: A human 3D platform for personalised medicine 120
COVID-19 and liver cancer clinical trials: not everything is lost 120
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma 120
Autophagy: highlighting a novel player in the autoimmunity scenario 120
Lights and Shadows on Fibrates as Second-Line Therapy of Primary Biliary Cholangitis 116
COVID-19 Digestive System Involvement and Clinical Outcomes in a Large Academic Hospital in Milan, Italy 113
Interferon α and its contribution to autoimmunity 112
Prevalence and clinical significance of intrahepatic cholangiocellular carcinoma with radiological enhancement pattern mimicking hepatocellular carcinoma 112
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 112
Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis 111
Is autoimmunity a matter of sex? 111
The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis 111
Macrophage morphology correlates with single-cell diversity and prognosis in colorectal liver metastasis 109
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 108
Apotopes and innate immune system: Novel players in the primary biliary cirrhosis scenario 107
Biliary apotopes and antimitochondrial antibodies activate innate immune responses in primary biliary cirrhosis 107
High mortality in COVID-19 patients with mild respiratory disease 106
The X chromosome and immune associated genes 105
Telomere dysfunction in peripheral blood mononuclear cells from patients with primary biliary cirrhosis 104
Advances in pharmacotherapy for primary biliary cirrhosis 104
Autoimmune hepatitis type 2 associated with an unexpected and transient presence of primary biliary cirrhosis-specific antimitochondrial antibodies: a case study and review of the literature 104
Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosis 103
Autoimmunity and Turner's syndrome 103
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 102
Definition of human autoimmunity - autoantibodies versus autoimmune disease 102
Safety of vedolizumab in liver transplant recipients: A systematic review 102
Tumor-Infiltrating Lymphocytes and Macrophages in Intrahepatic Cholangiocellular Carcinoma. Impact on Prognosis after Complete Surgery 101
Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry 101
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3‐infected patients within the Italian network VIRONET‐C 101
An individualized algorithm to predict mortality in COVID-19 pneumonia: a machine learning based study 100
Hepatitis C virus eradication with DAA and liver cancer recurrence: is the best the enemy of the good? 100
Etiopathogenesis of primary biliary cirrhosis 100
Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma 100
Melatonin exerts by an autocrine loop antiproliferative effects in cholangiocarcinoma; its synthesis is reduced favoring cholangiocarcinoma growth 100
HLA Class II antigens associated with lupus nephritis in Italian SLE patients 99
The Pathogenesis of Primary Biliary Cholangitis: A Comprehensive Review 99
The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicine 99
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis : a multicenter study of 664 patients and 1992 healthy controls 99
A second update on mapping the human genetic architecture of COVID-19 98
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy 98
Benign liver tumors: Diagnostics and treatment 98
Primary biliary cholangitis 98
Goals of treatment for improved survival in primary biliary cholangitis: treatment target should be bilirubin within the normal range and normalization of alkaline phosphatase 97
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 97
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 97
The risk of Liver Cancer in Autoimmune Liver Diseases 96
Treatment with PEG-interferon and ribavirin for chronic hepatitis C increases neutrophil and monocyte chemotaxis 96
Hepatic and pulmonary involvement in a patient with PR3-ANCA vasculitis following SARS-CoV-2 vaccination: a case report 95
Changes in the Epidemiology of Primary Biliary Cholangitis 95
Intrahepatic cholangiocellular carcinoma with radiological enhancement patterns mimicking hepatocellular carcinoma 95
No clinical impact of HCV RNA determination at the end of treatment in patients receiving directly acting antivirals 94
Antimitochondrial Antibodies: from Bench to Bedside 94
Primary biliary cholangitis: a comprehensive overview. 93
Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study 93
Increased loss of the Y chromosome in peripheral blood cells in male patients with autoimmune thyroiditis 92
Y chromosome loss in male patients with primary biliary cirrhosis 91
Making sense of Autoantibodies in Cholestatic Liver Diseases 91
Implications of genome-wide association studies in novel therapeutics in primary biliary cirrhosis 91
Role of liver biopsy in hepatocellular carcinoma 91
Peak inflammation in atherosclerosis, primary biliary cirrhosis and autoimmune arthritis is counter-intuitively associated with regulatory T cell enrichment 91
The X-Factor in Primary Biliary Cirrhosis: Monosomy X and Xenobiotics 90
Molecular and Immunological Characterization of Biliary Tract Cancers: A Paradigm Shift Towards a Personalized Medicine 90
Identifying medical professionals at risk for in-hospital COVID-19 infection: a snapshot during a "tsunami" highlighting unexpected risks 90
Lymphoid infiltrate predicts prognosis of mass-forming intrahepatic cholangiocarcinoma undergoing complete liver resection 89
Management of patients with autoimmune liver disease during COVID-19 pandemic 89
Refining surgical therapy of liver cancer in cirrhosis: etiology makes the difference 88
Liver Injury Induced by Immune Checkpoint Inhibitors: An Affordable Risk of Cancer Therapy? 88
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis 88
Is the outcome after hepatectomy for transitional hepatocholangiocarcinoma different from that of hepatocellular carcinoma and mass-forming cholangiocarcinoma? A case-matched analysis 88
The Shifting Paradigm of Prognostic Factors of Colorectal Liver Metastases: From Tumor-Centered to Host immune-Centered Factors 87
Letter to the Editor: might denosumab fit in PBC treatment? 86
Primary biliary cirrhosis and autoimmune hepatitis: apotopes and epitopes 86
Geoepidemiology, Genetic and Environmental Risk Factors for PBC 86
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy 86
Mesenchymal Stem Cells to Treat Digestive System Disorders: Progress Made and Future Directions 84
Genetics and epigenetics of primary biliary cirrhosis 84
Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, metabolic syndrome and hepatocellular carcinoma-a composite scenario 84
Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals 84
The immunological potential of galectin-1 and -3 84
Infermieristica clinica in medicina interna 84
Sarcopenia is common in patients with cirrhosis and unresectable HCC treated by transarterial embolization but is not associated with increased rates of complications 83
What gastroenterologists should know about SARS-CoV 2 vaccine: World Endoscopy Organization perspective 83
Totale 10.591
Salva come PNG Salva come JPEG
Categoria #
all - tutte 115.361
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.361
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022778 0 0 0 178 8 11 22 109 89 92 201 68
2022/20232.567 349 128 244 319 234 221 13 187 459 205 162 46
2023/20241.616 120 146 347 73 46 220 118 99 34 32 133 248
2024/20252.514 55 51 22 60 61 317 224 254 349 566 275 280
2025/20266.652 900 410 504 602 199 255 1.781 327 389 417 326 542
2026/20272.975 650 683 1.170 472 0 0 0 0 0 0 0 0
Totale 18.697